Ionis Pharmaceuticals, Inc.
IONS
$32.61
-$0.92-2.74%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.90% | -1,026.51% | 4.70% | 22.31% | -14.86% |
| Total Depreciation and Amortization | -4.49% | -6.15% | -1.75% | -1.93% | 0.80% |
| Total Amortization of Deferred Charges | -1.50% | 0.60% | -1.29% | 12.91% | 12.18% |
| Total Other Non-Cash Items | -2.47% | 95.07% | -23.00% | 169.14% | -18.76% |
| Change in Net Operating Assets | 9.55% | -572.70% | -129.99% | -197.89% | 17.24% |
| Cash from Operations | -0.56% | -453.38% | -5.47% | -23.13% | -11.90% |
| Capital Expenditure | -179.92% | -3,213.19% | -322.98% | 48.10% | 57.10% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 127.10% | 440.37% | -568.21% | -15.75% | 125.57% |
| Cash from Investing | 123.98% | 355.36% | -595.98% | -10.16% | 123.37% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -7.69% | -117,123.68% | 99.93% | 99.99% | 0.00% |
| Issuance of Common Stock | -90.51% | -98.95% | 13,200.13% | 8.62% | 822.23% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -90.67% | -208.33% | 1,637.32% | -98.22% | -95.21% |
| Foreign Exchange rate Adjustments | 303.51% | -247.27% | 330.26% | -132.86% | -209.62% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 143.90% | -296.01% | 155.84% | -147.42% | -254.73% |